Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FM101 in Ocular Hypertension and Healthy Volunteers
NCT04585100Phase 2Unknown
- Sponsor
- Future Medicine
- Start
- Oct 2020
- Primary completion
- Jan 2023
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 2 trial of FM101 in ocular hypertension, open-angle glaucoma (OAG), sponsored by Future Medicine. Status: unknown.
02
Drugs
FM101
03
Conditions
ocular hypertensionopen-angle glaucoma (OAG)
Beyond the preview
Go deeper on NCT04585100.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04585100.